UK markets close in 3 hours 7 minutes

Core Laboratories N.V. (CLB)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
17.07+0.54 (+3.27%)
At close: 04:00PM EDT
17.07 0.00 (0.00%)
After hours: 05:30PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close16.53
Open17.84
Bid0.00 x 900
Ask19.00 x 1000
Day's range16.47 - 17.92
52-week range13.82 - 27.95
Volume676,674
Avg. volume435,450
Market cap796.561M
Beta (5Y monthly)2.43
PE ratio (TTM)33.47
EPS (TTM)0.51
Earnings date30 Jan 2024 - 05 Feb 2024
Forward dividend & yield0.04 (0.23%)
Ex-dividend date03 May 2024
1y target est19.38
  • Thomson Reuters StreetEvents

    Q1 2024 Core Laboratories Inc Earnings Call

    Q1 2024 Core Laboratories Inc Earnings Call

  • Zacks

    Core Laboratories (CLB) Q1 Earnings and Sales Beat Estimates

    Core Laboratories' (CLB) second-quarter 2024 revenues are anticipated to be in the $130-$136 million range, while the operating income is estimated to be in the band of $14.5-$17.3 million.

  • PR Newswire

    CORE LAB REPORTS FIRST QUARTER 2024 RESULTS

    Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported first quarter 2024 revenue of $129,600,000. Core's operating income was $8,600,000, with diluted earnings per share ("EPS") of $0.07, all in accordance with U.S. generally accepted accounting principles ("GAAP"). Operating income, ex-items, a non-GAAP financial measure, was $14,900,000, yielding operating margins of 12%, and EPS, ex-items, of $0.19. During the first quarter of 2024, the Company recorded: 1) appr